Max Stenosis LAD Test

The left anterior descending artery is the single most important coronary vessel in your body. It feeds the front wall of your heart and supplies the largest territory of heart muscle, which is why a major blockage here is sometimes called a widow-maker. Max Stenosis LAD tells you, in plain percentage terms, how narrowed the worst spot in that artery is right now.

Unlike cholesterol numbers that predict risk over years, this is a direct anatomical look at what is actually happening inside the artery. A 70 percent narrowing means there is a real, physical bottleneck in the vessel that supplies the front of your heart. That is information no blood panel can give you.

How the Number Is Measured

Max Stenosis LAD comes from coronary imaging, usually a coronary CT angiogram or an invasive coronary angiogram. A radiologist or cardiologist identifies the most narrowed point along the LAD (left anterior descending artery) and reports it as a percent reduction in lumen diameter compared with a healthy nearby segment. Two studies that look identical on a paper number can behave very differently in real life, which is why modern reports often pair the anatomical narrowing with a functional measure of how much blood actually gets through.

Newer photon-counting CT scanners reduce apparent stenosis severity by about 11 percent compared with older CT systems, often downgrading a lesion into a less severe category. The scanner generation and reader expertise both matter, and AI-assisted reads now match expert human readers for moderate and severe LAD narrowing.

Heart Attack Risk

This is the most actionable use of the number. In the CASS Registry, lesions narrowing the LAD by 90 to 98 percent carried the highest three-year risk of an anterior wall heart attack, with a roughly 15 percent event rate over three years. Critical proximal LAD narrowing is also the lesion behind Wellens syndrome and the de Winter ECG pattern, both of which signal an imminent large anterior infarction unless the vessel is opened.

After a procedure to open a coronary artery (PCI), people with LAD involvement face roughly double the rate of major adverse cardiovascular events compared with people whose disease is elsewhere. Location inside the LAD also matters, with proximal lesions carrying more weight than distal ones.

Whether the Narrowing Is Actually Restricting Blood Flow

A 60 percent narrowing on the image does not automatically mean blood flow is impaired. Functional tests answer the second half of the question: is this stenosis actually starving the heart muscle of blood? Two measurements dominate.

• Fractional flow reserve (FFR): measured invasively with a pressure wire. A value above 0.80 means the lesion is not flow-limiting. In long-term follow-up of people with proximal LAD lesions and FFR above 0.80, medical therapy alone produced survival similar to an age- and sex-matched general population.
• Coronary flow reserve (CFR): measured non-invasively with Doppler echocardiography. A CFR below 2.0 suggests the narrowing is flow-limiting. CFR of 2.0 or higher had 88 to 95 percent sensitivity and 82 to 89 percent negative predictive value for ruling out a significant LAD lesion in intermediate stenoses.

FFR also behaves differently in the LAD than in other coronary arteries. Because the LAD supplies a larger muscle territory, the same anatomic narrowing tends to produce a lower FFR than in the right coronary or circumflex arteries. The 0.80 cutoff still applies, but vessel-specific judgment is needed.

Decision Thresholds Used in Practice

These cutpoints come from imaging cohorts and intervention trials, not from a single guideline reference range. They are best interpreted alongside symptoms, plaque features, and any functional test results.

These ranges come from CAD-RADS reporting standards used in coronary CT angiography and from observational cohorts including CASS and the FFR proximal LAD long-term follow-up study. Imaging method and reader experience can shift the apparent number by 10 percent or more, so compare results from the same imaging center over time.

Why Proximal LAD Matters More Than Distal LAD

Where the narrowing sits inside the LAD changes the stakes. A proximal lesion threatens the entire front wall of the heart, while a small distal narrowing threatens a much smaller territory. In multivessel disease that involves the proximal LAD, bypass surgery is associated with lower five-year rates of death, heart attack, and stroke than stenting. For distal lesions, the difference shrinks. A good report will tell you the segment, not just the percent.

Plaque Features That Add Risk

The percent narrowing is one part of the picture. Modern CT scans also describe what the plaque is made of. Lipid-rich non-culprit plaques in the LAD, defined by a maxLCBI4mm above 400 and a small minimal lumen area, were strongly predictive of future plaque-level events in the Lipid-Rich Plaque study. Automated plaque analysis combining stenosis percent, plaque burden, necrotic core, and remodeling predicted major adverse cardiac events with an AUC around 0.94, far above clinical risk factors alone.

People with diabetes carry more plaque, more non-calcified plaque, and a higher max stenosis in the LAD even when their disease is technically non-obstructive. A diabetic with nonobstructive disease looks, on imaging, like a non-diabetic with obstructive disease.

When Results Can Be Misleading

• Scanner type: photon-counting CT systems reduce apparent stenosis severity by about 11 percent compared with conventional CT, often downgrading the same lesion into a milder category. Same artery, different number.
• Heavy calcification: dense calcium can cause blooming on conventional CT and inflate the apparent narrowing. This is one of the main reasons photon-counting CT changes the read.
• Heart rate and motion: higher heart rates during the scan blur the image and can overestimate narrowing. Beta blockers are often given before the scan for this reason.
• Reader variability: AI-assisted reading is roughly as accurate as expert human readers, but visual percent estimates between two clinicians can differ by a full CAD-RADS category for the same image.

Tracking Your Trend

Max Stenosis LAD is not a number to check every six months. It moves slowly. Plaque can regress with aggressive lipid lowering, but the changes show up over 12 to 24 months of imaging, not weeks. For most people, a baseline coronary CT angiogram in your 40s or 50s, with a repeat scan in 2 to 5 years depending on the initial result and risk factors, is the right cadence. People with established plaque or high Lp(a) often benefit from a tighter interval.

What matters more than a single percent number is direction. A stable 40 percent over five years on the same scanner is reassuring. A 40 percent that becomes 60 percent in two years is a different conversation. Always compare scans from the same imaging center on the same scanner generation when possible, because the technology itself moves the apparent number.

What to Do If Your Number Is Elevated

An elevated Max Stenosis LAD is a result that should change your next steps, not just your label. The decision pathway depends on the number, your symptoms, and the rest of the imaging.

• Anything 50 percent or higher: book a cardiology consult. For intermediate lesions in the 50 to 69 percent range, the next test is usually a functional measure (FFR, CFR, or stress imaging) to decide whether the narrowing is actually limiting blood flow.
• 70 percent or higher, especially proximal: this generally warrants a direct conversation about revascularization, particularly if symptoms are present or there is multivessel involvement.
• 90 to 98 percent: this is the highest anterior heart attack risk band identified in the CASS Registry. Urgent cardiology evaluation, not next month.
• Lipid panel and Lp(a): every elevated result should trigger a full lipid workup including ApoB and a one-time Lp(a) if you have not already measured it. These tell you what is driving the plaque and how aggressively to treat it.

If you have not seen a preventive cardiologist or lipidologist yet, an elevated Max Stenosis LAD is the result that should send you to one. Primary care can manage standard lipid targets, but aggressive plaque regression strategies, advanced lipid-lowering agents, and decisions about functional testing benefit from a specialist.